|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-7-22
|
|
pubmed:abstractText |
Tacrolimus is a potent calcineurin inhibitor that was introduced to heart transplantation in the early 1990s. The side-effect profile of tacrolimus is more favorable than that of cyclosporine and some reports have suggested an advantage of tacrolimus in the treatment of rejection. The present study was undertaken to determine whether a late conversion to tacrolimus affords these benefits to heart transplant recipients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1053-2498
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
723-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12873539-Adult,
pubmed-meshheading:12873539-Biological Markers,
pubmed-meshheading:12873539-Blood Glucose,
pubmed-meshheading:12873539-Blood Pressure,
pubmed-meshheading:12873539-California,
pubmed-meshheading:12873539-Cholesterol,
pubmed-meshheading:12873539-Creatinine,
pubmed-meshheading:12873539-Cyclosporine,
pubmed-meshheading:12873539-Diastole,
pubmed-meshheading:12873539-Female,
pubmed-meshheading:12873539-Follow-Up Studies,
pubmed-meshheading:12873539-Graft Rejection,
pubmed-meshheading:12873539-Heart Transplantation,
pubmed-meshheading:12873539-Humans,
pubmed-meshheading:12873539-Immunosuppressive Agents,
pubmed-meshheading:12873539-Male,
pubmed-meshheading:12873539-Middle Aged,
pubmed-meshheading:12873539-Myocardial Ischemia,
pubmed-meshheading:12873539-Postoperative Care,
pubmed-meshheading:12873539-Postoperative Complications,
pubmed-meshheading:12873539-Recurrence,
pubmed-meshheading:12873539-Steroids,
pubmed-meshheading:12873539-Survival Analysis,
pubmed-meshheading:12873539-Systole,
pubmed-meshheading:12873539-Tacrolimus,
pubmed-meshheading:12873539-Time Factors,
pubmed-meshheading:12873539-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience.
|
|
pubmed:affiliation |
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA. clajoie@sympatico.ca
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
